You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 55 No. 4, April 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Book Reviews
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Applications of Neurotrophic Factors

by Stuart C. Apfel, 209 pp, with illus, $85, Philadelphia, Pa, Lippincott-Raven Publishers, 1997.

Arch Neurol. 1998;55:575.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

It is difficult to imagine a more well-written, succinct yet thorough, authoritative, and fully referenced treatise on neurotrophic factors. Apfel systematically takes the reader through the history and biology of neurotrophic factors, current clinical experience of their use in the treatment of neurological disorders (including peripheral neuropathies, amyotrophic lateral sclerosis, Parkinson disease, and Alzheimer disease), and future prospects and challenges regarding their use. More factual material about neurotrophic factors was presented than I knew existed. Although a superb reference, many clinicians might find this information to be more than they wanted or needed to know, and the price too high to add this book to their personal library. Concerning the current optimism and enthusiasm regarding the future of neurotrophic factors in the clinical practice of neurology, Apfel offers this important reminder, "An important caveat to keep in mind is that much of the current rationale behind neurotrophic therapy . . . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.